In clinical trials, common side effects included gastrointestinal disorders (nausea, vomiting, diarrhoea, constipation), muscle spasms, fatigue, hair loss, and dysgeusia (distortion of the sense of taste). The effects were mostly mild to moderate.
Vismodegib
Etalocib
Duvelisib
Selpercatinib
Enasidenib
Idelalisib
Ivosidenib
Brigatinib